isotretinoin

(redirected from Absorica)
Also found in: Dictionary.

isotretinoin

 [i″so-tret´ĭ-no-in]
a synthetic form of retinoic acid (13-cis-retinoic acid), used orally to clear cystic and conglobate acne.
Miller-Keane Encyclopedia and Dictionary of Medicine, Nursing, and Allied Health, Seventh Edition. © 2003 by Saunders, an imprint of Elsevier, Inc. All rights reserved.

i·so·tret·i·noin

(ī'sō-tret'i-noyn),
A retinoid used to treat severe recalcitrant cystic acne; a known human teratogen.
Farlex Partner Medical Dictionary © Farlex 2012

isotretinoin

(ī′sō-trĕt′n-oin′)
n.
A synthetic isomer of retinoic acid that inhibits sebaceous gland secretion and is used in the treatment of severe nodular acne. It can cause birth defects if taken during pregnancy.
The American Heritage® Medical Dictionary Copyright © 2007, 2004 by Houghton Mifflin Company. Published by Houghton Mifflin Company. All rights reserved.

isotretinoin

Retinoic acid, 13-cis retinoic acid A retinoid used to treat acne and psoriasis and may ↓ tumor development Side effects Inflammation of skin and mucosa, hepatitis
McGraw-Hill Concise Dictionary of Modern Medicine. © 2002 by The McGraw-Hill Companies, Inc.

i·so·tret·i·no·in

(ī'sō-tret'i-nō'in)
A retinoid used to treat severe recalcitrant cystic acne; a known human teratogen.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012

isotretinoin

A RETINOID drug used to treat ACNE. The oral preparation is used under strictly controlled conditions to exclude pregnancy because of the known risks to the fetus. Brand names are Roaccutane, and, for external use Isotrex and Isotrexin.
Collins Dictionary of Medicine © Robert M. Youngson 2004, 2005

Isotretinoin

A powerful vitamin A derivative used in the treatment of acne. It can promote scarring after skin resurfacing procedures.
Mentioned in: Acne, Skin Resurfacing
Gale Encyclopedia of Medicine. Copyright 2008 The Gale Group, Inc. All rights reserved.

i·so·tret·i·no·in

(ī'sō-tret'i-nō'in)
A retinoid used to treat severe recalcitrant cystic acne; known human teratogen.
Medical Dictionary for the Dental Professions © Farlex 2012
References in periodicals archive ?
Absorica royalty revenues in Q2 2019 were disappointing at $2.2 million compared to $3.8 million in Q2 2018.
The decrease in Adjusted EBITDA for Q2 2019 was driven by the decrease in Absorica royalties and to a lesser extent due to the timing of certain Clozaril orders in Canada.
Ranbaxy Laboratories Inc, a wholly owned subsidiary of Ranbaxy Laboratories Limited, announced yesterday that it has commenced a sales and promotion launch of Absorica (Isotretinoin) Capsules.
Absorica is indicated for the treatment of severe recalcitrant nodular acne in patients 12 years of age and older.
Due to its high lipophilicity, oral absorption of isotretinoin is enhanced when given with a high-fat meal, however, Absorica, which is formulated using patented Lidose(r) technology, can be given without regards to meals.
Ashish Anvekar said, "We are most pleased to make Absorica available as a valuable option for dermatologists and a subset of patients who suffer from severe recalcitrant nodular acne.
Absorica is expected to be launched in the US in the fourth quarter of 2012.
The company said that the approval of Absorica represents its third US FDA approval and most important milestone to date.
"We are thrilled to make Absorica available as a valuable option for the dermatologists and patients who need treatment for severe recalcitrant nodular acne.
"Approval of Absorica represents our third FDA approval and most important milestone to date, reflecting the great work by our Scientific Affairs team at Cipher and our partner, Galephar Pharmaceutical Research," said Larry Andrews, President and CEO of Cipher.